PALBIK PHARMA PRIVATE LIMITED
PALBIK PHARMA PRIVATE LIMITED is a JHARKHAND based PRIVATE LIMITED company, Registered at dated 03-NOV-2010 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of PALBIK PHARMA PRIVATE LIMITED is U51909JH2010PTC014481 and registration number is 014481.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies JHARKHAND India. Authorized share capital of PALBIK PHARMA PRIVATE LIMITED is Rs. 500000 and its paid up capital is Rs. 300000. It aspire to serve in TRADING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on 2014-03-31 and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2015-03-31.
PALBIK PHARMA PRIVATE LIMITED has 3 directors GOPAL NAND JHA, BIKASH KUMAR SINGH, BHUSHAN SAHAY,
The registered Email address of PALBIK PHARMA PRIVATE LIMITED is gopal.mof@hotmail.com and its registered address is PLOT NO. 521, JHARKHAND X-RAY GALI KANKE BLOCK KANKE RANCHI JHARKHAND INDIA 834006 JHARKHAND JHARKHAND india 834006.
The current status of PALBIK PHARMA PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
PALBIK PHARMA PRIVATE LIMITED
JHARKHAND
ACTIVE
TRADING
U51909JH2010PTC014481
03 NOV 2010
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
500000
300000
2014-03-31
2015-03-31
CONTACT DETAILS
834006
INDIA
PLOT NO. 521, JHARKHAND X-RAY GALI KANKE BLOCK KANKE RANCHI JHARKHAND INDIA 834006
gopal.mof@hotmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
03245055 | GOPAL NAND JHA | Director | 03/11/2010 |
03245047 | BIKASH KUMAR SINGH | Director | 03/11/2010 |
07863109 | BHUSHAN SAHAY | Director | 29/06/2017 |
Details Updated by Companies
Quick Links
- All Registered company of JHARKHAND
- Company Registered in JHARKHAND
- All Registered company of RANCHI in JHARKHAND
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.